123 related articles for article (PubMed ID: 14521633)
1. Melatonin: structural characterization of its non-enzymatic mono-oxygenate metabolite.
Agozzino P; Avellone G; Bongiorno D; Ceraulo L; Filizzola F; Natoli MC; Livrea MA; Tesoriere L
J Pineal Res; 2003 Nov; 35(4):269-75. PubMed ID: 14521633
[TBL] [Abstract][Full Text] [Related]
2. Interactions of melatonin and its metabolites with the ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones.
Rosen J; Than NN; Koch D; Poeggeler B; Laatsch H; Hardeland R
J Pineal Res; 2006 Nov; 41(4):374-81. PubMed ID: 17014695
[TBL] [Abstract][Full Text] [Related]
3. Iodinated melatonin: preparation and characterization of the molecular structure by mass and 1H NMR spectroscopy.
Vakkuri O; Lämsä E; Rahkamaa E; Ruotsalainen H; Leppäluoto J
Anal Biochem; 1984 Nov; 142(2):284-9. PubMed ID: 6549370
[TBL] [Abstract][Full Text] [Related]
4. 2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist.
Duranti E; Stankov B; Spadoni G; Duranti A; Lucini V; Capsoni S; Biella G; Fraschini F
Life Sci; 1992; 51(7):479-85. PubMed ID: 1322481
[TBL] [Abstract][Full Text] [Related]
5. Reactions of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK) with the ABTS cation radical: identification of new oxidation products.
Than NN; Heer C; Laatsch H; Hardeland R
Redox Rep; 2006; 11(1):15-24. PubMed ID: 16571272
[TBL] [Abstract][Full Text] [Related]
6. Reactions of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK) with the tyrosine side-chain fragment, 4-ethylphenol.
Nowak A; Rahman H; Heer C; Schueth A; Laatsch H; Hardeland R
Redox Rep; 2008; 13(3):102-8. PubMed ID: 18544227
[TBL] [Abstract][Full Text] [Related]
7. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence.
Reiter RJ; Tan DX; Manchester LC; Qi W
Cell Biochem Biophys; 2001; 34(2):237-56. PubMed ID: 11898866
[TBL] [Abstract][Full Text] [Related]
8. Oxidation of melatonin by oxoferryl hemoglobin: a mechanistic study.
Tesoriere L; Avellone G; Ceraulo L; D'Arpa D; Allegra M; Livrea MA
Free Radic Res; 2001 Dec; 35(6):633-42. PubMed ID: 11811517
[TBL] [Abstract][Full Text] [Related]
9. Reactions of the melatonin metabolite AMK (N1-acetyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compounds, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMK.
Guenther AL; Schmidt SI; Laatsch H; Fotso S; Ness H; Ressmeyer AR; Poeggeler B; Hardeland R
J Pineal Res; 2005 Oct; 39(3):251-60. PubMed ID: 16150105
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, NMR conformational analysis and pharmacological evaluation of 7,7a,13,14-tetrahydro-6H-cyclobuta[b]pyrimido[1,2-a:3,4-a']diindole analogues as melatonin receptor ligands.
Attia MI; Güclü D; Hertlein B; Julius J; Witt-Enderby PA; Zlotos DP
Org Biomol Chem; 2007 Jul; 5(13):2129-37. PubMed ID: 17581657
[TBL] [Abstract][Full Text] [Related]
11. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation.
Tan DX; Manchester LC; Reiter RJ; Plummer BF; Hardies LJ; Weintraub ST; Vijayalaxmi ; Shepherd AM
Biochem Biophys Res Commun; 1998 Dec; 253(3):614-20. PubMed ID: 9918777
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of butyrylcholinesterase by singlet oxygen-generated melatonin derivatives.
Moleda Z; Wojtasiewicz K; Panasiewicz M; Czarnocki Z
J Pineal Res; 2010 Aug; 49(1):55-9. PubMed ID: 20459459
[TBL] [Abstract][Full Text] [Related]
13. Identification of the factors affecting the rate of deactivation of hypochlorous acid by melatonin.
Dellegar SM; Murphy SA; Bourne AE; DiCesare JC; Purser GH
Biochem Biophys Res Commun; 1999 Apr; 257(2):431-9. PubMed ID: 10198231
[TBL] [Abstract][Full Text] [Related]
14. Oxidation of melatonin by singlet molecular oxygen (O2(1deltag)) produces N1-acetyl-N2-formyl-5-methoxykynurenine.
de Almeida EA; Martinez GR; Klitzke CF; de Medeiros MH; Di Mascio P
J Pineal Res; 2003 Sep; 35(2):131-7. PubMed ID: 12887657
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and conformational study of 3,4-carbocyclic bridged indole melatonin and serotonin analogues.
Bedini A; Di Giacomo B; Gatti G; Spadoni G
Bioorg Med Chem; 2005 Aug; 13(15):4651-7. PubMed ID: 15916895
[TBL] [Abstract][Full Text] [Related]
16. Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS.
Brandt SD; Freeman S; Fleet IA; McGagh P; Alder JF
Analyst; 2004 Nov; 129(11):1047-57. PubMed ID: 15508033
[TBL] [Abstract][Full Text] [Related]
17. A cyclic isomer of 2-hydroxymelatonin: a novel metabolite of melatonin.
Vakkuri O; Tervo J; Luttinen R; Ruotsalainen H; Rahkamaa E; Leppäluoto J
Endocrinology; 1987 Jun; 120(6):2453-9. PubMed ID: 3569138
[TBL] [Abstract][Full Text] [Related]
18. Monoepoxy octadecadienoates and monoepoxy octadecatrienoates 1: NMR spectral characterization.
Cui PH; Duke RK; Duke CC
Chem Phys Lipids; 2008 Apr; 152(2):122-30. PubMed ID: 18339314
[TBL] [Abstract][Full Text] [Related]
19. Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.
Jellimann C; Mathé-Allainmat M; Andrieux J; Renard P; Delagrange P; Langlois M
J Med Chem; 1999 Mar; 42(6):1100-5. PubMed ID: 10090792
[TBL] [Abstract][Full Text] [Related]
20. Reassessing the melatonin pharmacophore--enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue.
Rivara S; Diamantini G; Di Giacomo B; Lamba D; Gatti G; Lucini V; Pannacci M; Mor M; Spadoni G; Tarzia G
Bioorg Med Chem; 2006 May; 14(10):3383-91. PubMed ID: 16431121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
